The threat to CSL is based on VYVGART impact on CIDP patients. That is still on.
- Forums
- ASX - By Stock
- Vyvgart fails
The threat to CSL is based on VYVGART impact on CIDP patients....
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$293.69 |
Change
-2.310(0.78%) |
Mkt cap ! $142.3B |
Open | High | Low | Value | Volume |
$294.28 | $295.68 | $293.35 | $44.62M | 151.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 67 | $293.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$293.71 | 20 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 431 | 293.690 |
9 | 147 | 293.680 |
2 | 7 | 293.670 |
1 | 5 | 293.660 |
2 | 57 | 293.650 |
Price($) | Vol. | No. |
---|---|---|
293.730 | 18 | 2 |
293.740 | 4 | 1 |
293.800 | 113 | 2 |
293.820 | 8 | 1 |
293.860 | 38 | 2 |
Last trade - 12.36pm 18/09/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |